We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

EU Authorizes AstraZeneca COVID-19 Booster Dose

May 24, 2022
Vaxzevria brought in a total of $3.9 billion in revenue in 2021. Read More

FDA Lifts Clinical Hold on Ocugen COVID-19 Vaccine Clinical Trial

May 24, 2022
The WHO granted the vaccine an emergency use listing (EUL) in November 2021 but suspended the supply in April following its inspection of the Bharat Biotech facility. Read More

Cepheid Gains Emergency Authorization for New Version of Its Xpert Xpress COVID-19 Test

May 23, 2022
The Xpert Xpress CoV-2plus test is authorized for screening asymptomatic individuals. Read More

CanSino Biologics’ COVID-19 Vaccine Gets EUL From the WHO

May 20, 2022
The WHO is recommending the vaccine for people age 18 years and older. Read More

FDA OKs Booster of Pfizer-BioNTech COVID-19 Vaccine for Kids Five to 11

May 18, 2022
The FDA has authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for children age five through 11 years. Read More

AstraZeneca Gains Rights to RQ Biotechnology’s COVID-19 Monoclonal Antibodies

May 18, 2022
“The COVID-19 pandemic has changed the landscape for immune therapies, including the use of monoclonal antibodies to protect vulnerable patients who can’t respond adequately to vaccination alone,” said Iskra Reic, AstraZeneca’s executive vice president for vaccines and immune therapies. Read More

FDA Provides Update on Woodside Acquisitions’ Recall of Its COVID-19 Tests

May 18, 2022
The FDA said it has received no reports of injuries, deaths, or adverse events associated with the recalled tests. Read More

ICER Says No to Molnupiravir, Yes to Paxlovid and Fluvoxamine for Outpatient COVID Treatment

May 16, 2022
Merck’s oral COVID treatment molnupiravir lacks adequate evidence to support claims that it’s any more effective than symptomatic care. Read More

NIH Shares COVID-19 Technologies With Medicines Patent Pool

May 16, 2022
The technologies are also made available through the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) program. Read More

South Africa Manufacturer Plans to Stop Making COVID-19 Vaccines

May 16, 2022
The plant has produced more than 200 million doses of COVID-19 vaccines. Read More

FDA Encourages Veru to Submit EUA Application for COVID-19 Therapy

May 13, 2022
In the wake of strongly positive data and an FDA go-ahead, Veru will seek an Emergency Use Authorization (EUA) for sabizabulin, its investigational COVID-19 therapy. Read More

Moderna Completes EUA Submission for Use of COVID-19 Vaccine in Children

May 13, 2022
Spikevax is not currently authorized or approved for children under 18. Read More
Previous 1 2 3 4 5 6 7 8 9 … 167 168 Next

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared

  • FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing